Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3M7FK
|
|||
| Drug Name |
CNSA-001
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Gastroparesis [ICD-11: DA41.00; ICD-9: 536.3] | Phase 2 | [1] | |
| Hyperphenylalaninemia [ICD-11: 5C50] | Phase 1/2 | [2] | ||
| Company |
Censa Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03712124) A Study of CNSA-001 in Women With Diabetic Gastroparesis. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT03519711) A Study of CNSA-001 in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.